Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vitamin and trace elements imbalance are very common in adult patients with newly diagnosed Celiac disease. | Sci Rep | 2025 | 40754594 | PubTator, text mining | PubMed |
| Improving synergistic drug combination prediction with signature-based gene expression features in oncology. | Front Pharmacol | 2025 | 40746727 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| Improving Outcomes of Single-Sided Deaf Cochlear Implant Users by Reducing Interaural Frequency and Loudness Mismatches through Device Programming. | Trends Hear | 2025 | 40739862 | PubTator, text mining | PubMed |
| Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. | Signal Transduct Target Ther | 2025 | 40739089 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines. | NPJ Breast Cancer | 2025 | 40738893 | PubTator, text mining | PubMed |
| FAT1-weighted MRI-guided focused ultrasound thalamotomy for essential tremor. | BMJ Neurol Open | 2025 | 40734993 | PubTator, text mining | PubMed |
| The Association Between COPD, Acute Exacerbations of COPD, and Survival in COPD, with Fat-Free Body Mass Index: A Systematic Review and Meta-Analysis. | Int J Chron Obstruct Pulmon Dis | 2025 | 40734724 | PubTator, text mining | PubMed |
| Molecular and Genetic Pathogenesis of Oral Cancer: A Basis for Customized Diagnosis and Treatment. | Biology (Basel) | 2025 | 40723400 | PubTator, text mining | PubMed |
| Immune factors and their role in tumor aggressiveness in glioblastoma: Atypical cadherin FAT1 as a promising target for combating immune evasion. | Cell Mol Biol Lett | 2025 | 40713501 | PubTator, text mining | PubMed |
| Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry. | Clin Cancer Res | 2025 | 40704901 | PubTator, text mining | PubMed |
| Antigens in membranous nephropathy: discovery and clinical implications. | Nat Rev Nephrol | 2025 | 40691733 | PubTator, text mining | PubMed |
| Genomic Signatures of Poor Prognosis in Merkel Cell Carcinoma: A Single-Institution Prospective Study. | Mol Cancer Res | 2025 | 40689859 | PubTator, text mining | PubMed |
| FAT1 mutation-related signature predicts survival risk and tumor immunogenicity in lung adenocarcinoma. | Front Genet | 2025 | 40672387 | PubTator, text mining | PubMed |
| Identification of genetic variants associated with Fabry nephropathy progression using whole-exome sequencing. | Mol Genet Metab | 2025 | 40663814 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of nicotinamide adenine dinucleotide metabolism-related genes to predict immune status and prognosis for head and neck squamous cell carcinoma patients. | Front Immunol | 2025 | 40661938 | PubTator, text mining | PubMed |
| Genomic and Clinical Predictors of Conversion in Initially Unresectable Colorectal Cancer Liver Metastases. | Ann Surg Oncol | 2025 | 40659890 | PubTator, text mining | PubMed |
| Understanding and overcoming CDK4/6 inhibitor resistance in HR+/HER2- metastatic breast cancer: clinical and molecular perspectives. | Ther Adv Med Oncol | 2025 | 40656600 | PubTator, text mining | PubMed |
| The Link Between Dietary Timing and Exercise Performance Through Adipocyte AMPKα2 Signaling. | Int J Mol Sci | 2025 | 40649840 | PubTator, text mining | PubMed |
| Fat-free mass index cutoff values for reduced muscle mass in older community-dwelling adults in Japan: A descriptive cohort study. | JPEN J Parenter Enteral Nutr | 2025 | 40641345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=11